Literature DB >> 12637691

Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke.

M Martiskainen1, T Pohjasvaara, J Mikkelsson, R Mäntylä, T Kunnas, P Laippala, E Ilveskoski, M Kaste, P J Karhunen, T Erkinjuntti.   

Abstract

BACKGROUND AND
PURPOSE: Elevated fibrinogen levels are suggested to increase the risk of myocardial infarction and stroke. Carriers of the A allele of the fibrinogen -455G/A polymorphism have increased plasma fibrinogen levels. We studied the association of this polymorphism with stroke subtype in the Stroke Aging Memory (SAM) cohort.
METHODS: The SAM cohort comprises 486 consecutive patients 55 to 85 years of age who, 3 months after ischemic stroke, completed a detailed stroke assessment. Stroke subtypes were examined with MRI. -455G/A genotype was determined by polymerase chain reaction. MRI and genotype data were available for the 299 patients who constitute the present study population.
RESULTS: Genotype distributions were 64.9% (GG), 31.8% (GA), and 3.3% (AA). In a logistic regression model with age, sex, hypertension, diabetes, hypercholesterolemia, hypertriglyceridemia, myocardial infarction, arrhythmia, atrial fibrillation, peripheral arterial disease, and smoking as possible confounders, there was a significant association between A+ genotype and >or=3 lacunar infarcts (odds ratio [OR], 2.57; 95% CI, 1.23 to 5.36; P=0.01). Hypertensive patients carrying the A allele had increased risk (OR, 4.24; 95% CI, 1.29 to 13.99; P=0.02) for >or=3 lacunar infarcts. A similar increase in risk was observed among smokers with the A+ genotype (OR, 2.67; 95% CI, 0.92 to 7.77; P=0.07).
CONCLUSIONS: Stroke patients carrying the A allele of the Bbeta-fibrinogen -455G/A polymorphism frequently presented with multiple lacunar infarcts. This association was stronger among hypertensives and smokers. These associations suggest that the A allele may predispose to atherothrombotic events in cerebrovascular circulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637691     DOI: 10.1161/01.STR.0000060029.23872.55

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.

Authors:  Elena V Zholdybayeva; Yerkebulan A Talzhanov; Akbota M Aitkulova; Pavel V Tarlykov; Gulmira N Kulmambetova; Aisha N Iskakova; Aliya U Dzholdasbekova; Olga A Visternichan; Dana Zh Taizhanova; Yerlan M Ramanculov
Journal:  Hum Genomics       Date:  2016-06-08       Impact factor: 4.639

2.  Association between Beta-Fibrinogen C148T Gene Polymorphism and Risk of Ischemic Stroke in a North Indian Population: A Case-Control Study.

Authors:  Amit Kumar; Shubham Misra; Pradeep Kumar; Ram Sagar; Kameshwar Prasad
Journal:  Pulse (Basel)       Date:  2016-10-12

3.  Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation.

Authors:  Dmitry A Zateyshchikov; Alexey N Brovkin; Dimitry A Chistiakov; Valery V Nosikov
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 4.  Cerebral small vessel disease: genetic risk assessment for prevention and treatment.

Authors:  Ada Lam; M Anne Hamilton-Bruce; Jim Jannes; Simon A Koblar
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

5.  Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort.

Authors:  Mika Martiskainen; Niku Oksala; Tarja Pohjasvaara; Markku Kaste; Anni Oksala; Pekka J Karhunen; Timo Erkinjuntti
Journal:  BMC Neurol       Date:  2014-06-22       Impact factor: 2.474

6.  The β-fibrinogen gene 455G/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA2DS2-VaSc score.

Authors:  Xiaofeng Hu; Junjun Wang; Yaguo Li; Jiong Wu; Song Qiao; Shanhu Xu; Jun Huang; Linhui Chen
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

7.  Hypertension and Cerebral Microangiopathy (Cerebral Small Vessel Disease): Genetic and Epigenetic Aspects of Their Relationship.

Authors:  L A Dobrynina; M R Zabitova; L A Kalashnikova; E V Gnedovskaya; M A Piradov
Journal:  Acta Naturae       Date:  2018 Apr-Jun       Impact factor: 1.845

8.  Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm.

Authors:  Katarzyna Oszajca; Konrad Wroński; Grażyna Janiszewska; Małgorzata Bieńkiewicz; Michał Panek; Jacek Bartkowiak; Janusz Szemraj
Journal:  Exp Ther Med       Date:  2012-06-12       Impact factor: 2.447

9.  Role of genetic changes in the progression of cardiovascular diseases.

Authors:  S A Sheweita; H Baghdadi; A R Allam
Journal:  Int J Biomed Sci       Date:  2011-12

10.  beta-Fibrinogen Gene -455 G/A Polymorphism in Korean Ischemic Stroke Patients.

Authors:  Seung-Han Lee; Myeong-Kyu Kim; Man-Seok Park; Seong-Min Choi; Joon-Tae Kim; Byeong-Chae Kim; Ki-Hyun Cho
Journal:  J Clin Neurol       Date:  2008-03-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.